The filing is a routine insider sale notice with immaterial size. Monitor for any pattern of larger insider sales in future filings, but this single notice carries no actionable signal.
ONC drugs
ONC drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $417.33entry
- T+1 · 7d ago +1.60%α +1.97% · $424.00
- T+5 · 16h ago −1.45%α +0.25% · $411.29
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Titus B. Ball, an officer of BeOne Medicines Ltd., filed a Form 144 notice of intent to sell 1,559 ADSs with an approximate market value of $632,277. The shares were acquired via option exercise under a registered plan. The sale is small relative to the company's $43B market cap and represents a routine insider transaction.
Key Facts
- Titus B. Ball (officer) filed Form 144 to sell 1,559 ADSs
- Approximate market value of sale: $632,277
- Shares acquired via exercise of options under a registered plan on November 6, 2026
- Sale intended to be executed on or after November 6, 2026
- Company market cap: $43.0B; sale represents ~0.0015% of market cap
Financial Impact
Sale of 1,559 ADSs worth approximately $632,277, negligible relative to $43B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- No additional context on Ball's total holdings or recent selling pattern is provided in the filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010793 |
| Document: 0001950047-26-010793-index.html | 0001950047-26-010793 |
| Document: 0001950047-26-010793.txt | 0001950047-26-010793 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers